
Dr. Sanjay Chaturvedi Steps Down As CEO Of Aurobindo Pharma’s Apitoria Pharma
Dr. Sanjay Chaturvedi has resigned as Chief Executive Officer (CEO) of Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd., effective May 4, 2026, citing a move to a different opportunity.
Dr. Chaturvedi earlier served as Executive Director and CEO of IOL Chemicals and Pharmaceuticals Ltd. He has over 25 years of experience across speciality chemicals, biotechnology, and pharmaceuticals. He has held roles at Dr. Reddy’s Laboratories, Praj Industries, Rohm and Haas, and Dow Chemicals. His work includes business operations, strategy, product development, and market expansion across regions. He holds degrees in chemistry from the University of Delhi, a PhD from Stony Brook University, and a management qualification from the Wharton School.




